Triple negative breast cancers (TNBC), which lack the expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), account for more breast cancer-related deaths even though they represent only 15-25 % of total breast cancers. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.